Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Strand

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Human Molecular Genetics|August 8, 2002
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effectsRuth Luthi-Carter, Andrew D Strand, Sarah A Hanson, et al.
Human Molecular Genetics|August 8, 2002
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brainRuth Luthi-Carter, Sarah A Hanson, Andrew D Strand, et al.
BMC Bioinformatics|April 21, 2006
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression dataLesley Jones, Darlene R Goldstein, Gareth Hughes, et al.
Human Molecular Genetics|September 27, 2005
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's diseaseCaroline L Benn, Christian Landles, He Li, et al.
Journal of Molecular Biology|April 19, 2020
A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive MoleculesZachary R Crook, Emily Girard, Gregory P Sevilla, et al.
Science Translational Medicine|March 6, 2020
A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposureMichelle L Cook Sangar, Emily J Girard, Gene Hopping, et al.
Cell Metabolism|October 24, 2006
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegenerationPatrick Weydt, Victor V Pineda, Anne E Torrence, et al.
Human Molecular Genetics|February 10, 2006
Regional and cellular gene expression changes in human Huntington's disease brainAngela Hodges, Andrew D Strand, Aaron K Aragaki, et al.
Human Molecular Genetics|May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosageAlexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
Nature Medicine|October 24, 2018
A biobank of patient-derived pediatric brain tumor modelsSebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Human Molecular Genetics|August 8, 2002
Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effectsRuth Luthi-Carter, Andrew D Strand, Sarah A Hanson, et al.
Human Molecular Genetics|August 8, 2002
Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brainRuth Luthi-Carter, Sarah A Hanson, Andrew D Strand, et al.
BMC Bioinformatics|April 21, 2006
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression dataLesley Jones, Darlene R Goldstein, Gareth Hughes, et al.
Human Molecular Genetics|September 27, 2005
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's diseaseCaroline L Benn, Christian Landles, He Li, et al.
Journal of Molecular Biology|April 19, 2020
A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive MoleculesZachary R Crook, Emily Girard, Gregory P Sevilla, et al.
Science Translational Medicine|March 6, 2020
A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposureMichelle L Cook Sangar, Emily J Girard, Gene Hopping, et al.
Cell Metabolism|October 24, 2006
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegenerationPatrick Weydt, Victor V Pineda, Anne E Torrence, et al.
Human Molecular Genetics|February 10, 2006
Regional and cellular gene expression changes in human Huntington's disease brainAngela Hodges, Andrew D Strand, Aaron K Aragaki, et al.
Human Molecular Genetics|May 24, 2007
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosageAlexandre Kuhn, Darlene R Goldstein, Angela Hodges, et al.
Nature Medicine|October 24, 2018
A biobank of patient-derived pediatric brain tumor modelsSebastian Brabetz, Sarah E S Leary, Susanne N Gröbner, et al.
Pageof 3